2024 Global Immunoassay Analyzers and Reagents--USA, Europe, Japan--2023 Supplier Shares and Competitive Analysis, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests Performed in Hospitals, Commercial/Private Labs and POC Locations--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunoassay market during the next five years. The report is available by section, and can be customized to specific information needs and budget. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables. RationaleThe immunoassay market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.Worldwide Market Overview%li%Estimates of facilities performing clinical chemistry and immunoassay tests by country.%li%Test volume and sales projections by country.Strategic Recommendations%li%New product development opportunities with significant market appeal.%li%Alternative market penetration strategies.%li%Potential market entry barriers and risks.Competitive Assessments%li%Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.%li%The companies analyzed in the report include: Abbott Laboratories, Agilent, Beckman Coulter/Danaher, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Fujifilm Wako, Fujirebio, Grifols, Instrumentation Laboratory/Werfen, Kyowa Medex, PerkinElmer, Quest Diagnostics, QuidelOrtho, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Tosoh
Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USMarket Segmentation Analysis%li%Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.%li%Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by country and market segment: Hospitals, Commercial/Private Laboratories, Physician Offices/Group Practices, Ambulatory Care CentersCurrent and Emerging Products%li%Analysis of current and emerging clinical chemistry and immunoassay tests.%li%Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.Technology Review%li%Assessment of current and emerging technologies, and their potential market applications.%li%Comprehensive lists of companies developing or marketing new technologies and products by test.
Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USMarket Segmentation Analysis%li%Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.%li%Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by country and market segment: Hospitals, Commercial/Private Laboratories, Physician Offices/Group Practices, Ambulatory Care CentersCurrent and Emerging Products%li%Analysis of current and emerging clinical chemistry and immunoassay tests.%li%Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.Technology Review%li%Assessment of current and emerging technologies, and their potential market applications.%li%Comprehensive lists of companies developing or marketing new technologies and products by test.
I. Introduction
II. Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Market and Technology Overview
A. Major Routine Chemistry Tests
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN, TOTAL
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. BNP
11. CALCIUM
12. CARDIO CRP
13. CHOLESTEROL
14. CHOLINESTERASE
15. CRP
16. CREATININE
17. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
18. FERRITIN
19. FRUCTOSAMINE
20. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
21. GLUCOSE
22. HIGH DENSITY LIPOPROTEIN (HDL)
23. HOMOCYSTEINE
24. HS-CRP
25. IRON
26. LACTATE DEHYDROGENASE (LDH)
27. MAGNESIUM
28. NT-PROBNP
29. PHOSPHORUS
30. PROTEIN
31. ST2
32. TRIGLYCERIDES
33. URIC ACID
34. TROPONIN
B. Therapeutic Drug Monitoring (TDM)
1. OVERVIEW
2. CARBAMAZEPINE
3. CYCLOSPORIN
4. DIGOXIN
5. EVEROLIMUS
6. GENTAMICIN
7. LAMOTRIGINE/LAMICTAL
8. LEVETIRACETAM
9. LIDOCAINE
10. LITHIUM
11. NAPA/PROCAINAMIDE
12. PHENYTOIN
13. QUINIDINE
14. SIROLIMUS
15. TACROLIMUS
16. THEOPHYLLINE
17. TOPIRIMATE
18. VALPROIC ACID
II. Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Market and Technology Overview
A. Major Routine Chemistry Tests
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN, TOTAL
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. BNP
11. CALCIUM
12. CARDIO CRP
13. CHOLESTEROL
14. CHOLINESTERASE
15. CRP
16. CREATININE
17. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
18. FERRITIN
19. FRUCTOSAMINE
20. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
21. GLUCOSE
22. HIGH DENSITY LIPOPROTEIN (HDL)
23. HOMOCYSTEINE
24. HS-CRP
25. IRON
26. LACTATE DEHYDROGENASE (LDH)
27. MAGNESIUM
28. NT-PROBNP
29. PHOSPHORUS
30. PROTEIN
31. ST2
32. TRIGLYCERIDES
33. URIC ACID
34. TROPONIN
B. Therapeutic Drug Monitoring (TDM)
1. OVERVIEW
2. CARBAMAZEPINE
3. CYCLOSPORIN
4. DIGOXIN
5. EVEROLIMUS
6. GENTAMICIN
7. LAMOTRIGINE/LAMICTAL
8. LEVETIRACETAM
9. LIDOCAINE
10. LITHIUM
11. NAPA/PROCAINAMIDE
12. PHENYTOIN
13. QUINIDINE
14. SIROLIMUS
15. TACROLIMUS
16. THEOPHYLLINE
17. TOPIRIMATE
18. VALPROIC ACID
